Alliances
Jing Medicine Technology will collaborate with ShanghaiTech University in a $100M partnership to discover and develop novel small molecule cancer drugs.
NetVation DL Medicine, a privately held Chengdu biotech, has entered a two-year research collaboration with Pfizer.
CR Pharma will be responsible for China clinical trials and other regulatory matters.
J&J inked a global collaboration deal with Theravance Biopharma to develop a drug for IBD.
Nektar is reportedly exploring various strategic options, including a possible sale, partnerships or licensing agreements.
Rare disease giant Shire plunked down an undisclosed sum to get its hands on a preclinical autoimmune drug candidate being developed by AB Biosciences.
Under the deal, The Salzman Group provides, among other services, clinical study management services in relation to the Phase 2 study evaluating the use of cannabidiol in the prevention of graft versus host disease.
The companies will collaborate on research to study a previously unrecognized role for peripheral immune cells in the pathology of central nervous system disorders.
Shanghai Fosun Pharma announced a $50M U.S. joint venture, a JV that includes two Fosun entities.
Bill Gates addressed thousands of top executives, bankers and investors at JPM this week.
PRESS RELEASES